Labcorp
Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Labcorp COVID-19 Antibody Testing Available Nationwide Learn more >>>
Tests for ABO blood grouping and the the Rh antigens D, C, E, c, and e (including test for “weak D,” if applicable)
2 - 4 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Whole blood
4 mL
1 mL
Lavender-top (EDTA) tube
Specimens should be tested as soon as possible or within 72 hours of collection. Samples that cannot be tested immediately should be stored at 2°C to 8°C. Do not freeze red cells.
Gross hemolysis; bacterial or other contamination
Determine ABO blood grouping and most probable zygosity for D(Rho) antigen. Zygosity for C, E, c, and e antigens is also determined. Paternal typing may aid in the prediction of Rh hemolytic disease of the newborn.
Abnormal plasma proteins, potent cold autoagglutinins, positive direct antiglobulin test, and in some cases bacteremia may interfere with test interpretation. Variable testing results may be observed with partial antigens which are rare variants of the Rho(D) antigen.
Hemagglutination
When a woman of childbearing age has anti-D, it is important for prognostic purposes to determine the probability that her husband is homozygous or heterozygous for the gene determining the D antigen. If a prenatal patient is Rh-negative and the father of her fetus is homozygous for D, the child will always be Rh positive. Approximately 50% of the children of a heterozygous father will be Rh-negative. Testing to determine zygosity involves testing the subject's red blood cells for D, C, E, c, and e antigens. The results of this testing are referred to as the Rh phenotype. The Rh phenotype is used to determine a “most probable” zygosity for D based upon correlation of these results with a frequency chart detailing most probable Rh genotypes. In the case of D, this must be done indirectly since there is no detectable allele for this gene. In the case of the alleles C and c and the alleles E and e, the zygosity of these genes may be directly determined from the phenotyping results. Rh phenotyping of the father may also be helpful for evaluating the potential for hemolytic disease of the newborn in the presence of maternal antibodies to C, c, E, or e antigens. See table.
Red Cell Antigen Typing | Most Probable Genotype | % Likelihood of Being Homozygous for D | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
D | C | E | c | e | Caucasian | Black | Mestizo* | White | Black | Mestizo* |
For further information, please contact LabCorp or consult the source for this chart. | ||||||||||
From American Association of Blood Banks. Technical Manual. 15th ed. Bethesda, Md: AABB Press; 2005. | ||||||||||
*Mestizo frequencies were derived from a study of Mexican and Mexican-American population studies. The term “Mestizo” is commonly used in Hispanic countries to describe persons of mixed European and American Indian ancestry. | ||||||||||
+ | + | O | + | + | CDe/cde | CDe/cDe | CDe/cde | 10 | 59 | 15 |
+ | + | O | O | + | CDe/CDe | CDe/CDe | CDe/CDe | 91 | 81 | 96 |
+ | O | + | + | + | cDE/cde | cDE/cDe | cDE/cde | 10 | 63 | 15 |
+ | O | + | + | O | cDE/cDE | cDE/cDE | cDE/cDE | 87 | 99 | 98 |
+ | + | + | + | + | CDe/cDE | CDe/cDE | CDe/cDE | 89 | 90 | 97 |
+ | O | O | + | + | cDe/cde | cDe/cde | cDe/cde | 6 | 46 | 8 |
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 006057 | Blood Grouping: | 883-9 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 016485 | Rh(D) | 1305-2 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 016493 | C | 948-0 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 016501 | E | 1021-5 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 016519 | c | 1159-3 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 016527 | e | 1165-0 | |
058008 | Rh-hr Genotype w/ABO Grouping | 93914-0 | 006587 | Rh-Genotype w/ABO | 1314-4 |
© 2020 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf